Allison Luo - 08 Sep 2021 Form 4 Insider Report for Prometheus Biosciences, Inc.

Role
Chief Medical Officer
Signature
/a/ Timothy K. Andrews, attorney-in-fact for Allison Luo
Issuer symbol
N/A
Transactions as of
08 Sep 2021
Net transactions value
$0
Form type
4
Filing time
15 Sep 2021, 20:09:03 UTC
Next filing
16 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +4,500 $0.000000 4,500 08 Sep 2021 Common Stock 4,500 $25.45 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in 12 equal monthly installments, commencing on September 1, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.